Does it really matter if you win or lose the genetic lottery?
By Joseph L Graves Jr,
The Lancet
| 01. 01. 2022
Kathryn Paige Harden, Professor of Psychology who leads the Developmental Behavior Genetics lab at the University of Texas at Austin, USA, is considered by many in her field as an up and coming superstar. Her book, The Genetic Lottery: Why DNA Matters for Social Equality, proposes that an individual's genetic composition, specifically related to their capacity to succeed at education, has an important role in determining their social outcomes. Harden examines the role that an individual's genetic predisposition may have in contributing to their position in society.
To make her case, Harden relies on, for example, results of studies that have associated polygenic scores (PGS) with educational attainment. PGS are derived from genome-wide association studies and identify variants that are statistically associated with a given phenotype. Harden summarises results from a series of PGS studies that indicate that they predict educational attainment, and that educational attainment is associated with a number of social outcomes including greater wealth. None of this is particularly controversial to people who know genetics. The traits of all organisms, behavioural and otherwise, result from the complex...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...